Effect of CoQ10 on the Endocrine Function of Skeletal Muscle

Sponsor
Medical University of Gdansk (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05412888
Collaborator
(none)
100
1
4
49
2

Study Details

Study Description

Brief Summary

Recent studies have also shown that repeated episodes of ischemia, followed by reperfusion (IPC), can contribute to the development of adaptive changes not only in the area of the heart muscle, but also in the structure of the skeletal muscles.

In the project, several research questions will be evaluated e.g. what is the relationship between oxidative stress parameters, uric acid concentration and nitric oxide degradation products in groups of people undergoing two-week training in ischemic training, or what is the relationship between the expression of genes associated with muscle cell growth (e.g. myostatin gene) and the effect of ischemia preconditioning training etc.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: CoQ10 supplementation
  • Procedure: Ischemic preconditioning training
  • Dietary Supplement: IPC training combined with CoQ10 supplementation
  • Dietary Supplement: Sham IPC combined with placebo
N/A

Detailed Description

Both in sport and medicine, methods are constantly sought that can significantly contribute to improving the ability of tissues to perform their functions and protecting them from effort-induced damage.

In a wide range of interests, especially in people treated for ischemic changes of cardiovascular diseases, are protocols of tissue preconditioning by transient ischemia which significantly contribute to the increase in blood flow in tissue structure.

Recent studies have also shown that repeated episodes of ischemia, followed by reperfusion (IPC), can contribute to the development of adaptive changes not only in the area of the heart muscle, but also in the structure of the skeletal muscles. There is still a lack of detailed research on genetic conditions related to adaptive changes in this area of interest.

In the project, the following research questions were posed:
  1. What is the relationship between oxidative stress parameters, uric acid concentration and nitric oxide degradation products in groups of people undergoing two-week training in IPC training, or 2 weeks of CoQ10 supplementation in the light of non-training and non-supplementation?

  2. What is the relationship between two weeks of lower limb ischemia preconditioning training, or CoQ10 supplementation, and the expression of genes associated with the stress response (HSF-1, NF-kB, TNF dependent glass)?

  3. What is the relationship between the expression of genes associated with muscle cell growth (e.g. myostatin gene) and the effect of preconditioning training by ischemia?

  4. What is the relationship between the expression of genes associated with intracellular metabolism and the effect of CoQ10 supplementation?

  5. What is the relationship between the expression of genes encoding enzymes of energy pathways (e.g. GAPDH, LDH) and IPC training or CoQ10 supplementation in the study group?

  6. How does IPC training or CoQ10 supplementation affect the expression of genes responsible for membrane transport, and the Hedgehog pathway in muscle cells (including Gli1)?

  7. How does IPC training affect the expression of transcription factors: Hif-1-alpha (hypoxia-induced factor) and NF-kB and selected genes dependent on their activity?

HYPOTHESIS The level of gene expression associated with oxidative stress, muscle fiber development, angiogenesis, muscle cell energy, and membrane transport will change under the influence of the use of preconditioning training by deficiency or CoQ10 supplementation

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Basic Science
Official Title:
The Effect of Ischemic Preconditioning and Physical Exercise on the Endocrine Function of Skeletal Muscle - the Effect of CoQ10 Supplementation. In Vivo and in Vitro Studies.
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Mar 31, 2023
Anticipated Study Completion Date :
Sep 30, 2026

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Supplemented population 300mg

Supplemented population 300mg/24h CoQ10 - 25 participants

Dietary Supplement: CoQ10 supplementation
Young men training endurance running will be supplemented with CoQ10

Experimental: Training and IPC preconditioning

Group subjected to training and preconditioning by ischemia (IPC training) - 25 participants,

Procedure: Ischemic preconditioning training
Young men training endurance running will undergo IPC training

Placebo Comparator: Control group (placebo)

Control group to CoQ10 supplementation (placebo)- 25 participants

Dietary Supplement: Sham IPC combined with placebo
Young men training endurance running will undergo sham IPC training combined with placebo supplementation

Sham Comparator: IPC control group

IPC control group - 25 participants

Dietary Supplement: IPC training combined with CoQ10 supplementation
Young men training endurance running will undergo IPC training combined with CoQ10 supplementation

Outcome Measures

Primary Outcome Measures

  1. The effects of IPC on physical performance [8 weeks]

    IPC training will be combined with endurance exercise and VO2max and serum Lactate will be measured

  2. The effects of CoQ10 supplementation on physical performance [8 weeks]

    CoQ10 supplementation combined with endurance training will be evaluated for endurance improvement in young men. VO2max, myokines, genes associated with the stress response will be measured

  3. The effects of CoQ10 supplementation and IPC on physical performance [8 weeks]

    CoQ10 supplementation combined with IPC and endurance training will be evaluated for endurance improvement in young men. VO2max, myokines, genes associated with the stress response, ulic acid will be measured

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 29 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes

Inclusion Criteria: - gender (males only),

  • not taking medication during the study,

  • good health (no concomitant injuries),

  • negative history of cardiovascular disorders, autonomic nervous system, mental disorders, cerebrospinal injuries and other diseases that may directly affect the results obtained.

Exclusion Criteria:

Lack of consent to participate in the research project or negative result of medical examinations.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jedrzej Antosiewicz GdaƄsk Pomorskie Poland 80-210

Sponsors and Collaborators

  • Medical University of Gdansk

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Medical University of Gdansk
ClinicalTrials.gov Identifier:
NCT05412888
Other Study ID Numbers:
  • MUGdansk CoQ10
First Posted:
Jun 9, 2022
Last Update Posted:
Jun 9, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Medical University of Gdansk
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 9, 2022